QUALITY OF LIFE IN OLDER ADULTS RECEIVING IMMUNE CHECKPOINT INHIBITOR THERAPY

Immune checkpoint inhibitors (ICIs) have generated significant excitement for their ability to extend survival in patients with lung, head and neck, and other cancers. In older adults with cancer, emerging research suggests that ICIs improve overall and progression-free survival, but few studies hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoogland, Aasha I, Eisel, Sarah L, Irizarry-Arroyo, Nathaly E, James, Brian, Mansfield, Jori, Lafranchise, Elizabeth A, Jim, Heather S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Session 1390 (Poster)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6840132/
http://dx.doi.org/10.1093/geroni/igz038.1145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6840132/
http://dx.doi.org/10.1093/geroni/igz038.1145

Ejemplares similares